Yoshindo

Lupin and Yoshindo JV YL Biologics declares achievement worldwide stage.

New Delhi, February 08, 2018: YL Biologics declared that a worldwide stage III clinical trial of its investigational Etanercept biosimilar (YLB113) has…

7 years ago